Human immunodeficiency virus transmission through artificial insemination.

Area of Science:

• Virology
• Public Health
• Reproductive Medicine

Background:

• Artificial insemination (AI) involves using donor semen for conception.
• The emergence of Human Immunodeficiency Virus type 1 (HIV-1) raised concerns about transmission through biological materials.
• Screening protocols for infectious agents in donated semen were evolving in the mid-1980s.

Purpose of the Study:

• To investigate the risk of HIV-1 transmission via artificial insemination using infected donor semen.
• To assess the prevalence of HIV-1 infection among women who received AI from seropositive donors.
• To provide evidence supporting the necessity of donor screening for HIV-1.

Main Methods:

• Retrospective analysis of AI procedures performed between 1978 and 1985.
• Identification of six HIV-1 seropositive semen donors through an antibody screening program.
• HIV-1 antibody testing of 134 women artificially inseminated with semen from these donors.

Main Results:

• One of 134 tested women was found to be HIV-1 seropositive.
• This woman had no other identified AIDS-associated risk factors, and her husband was seronegative.
• The observed transmission rate suggested a lower risk than previously reported by other studies.

Conclusions:

• Artificial insemination with infected donor semen is a potential route for HIV-1 transmission.
• The study underscores the critical importance of implementing routine HIV-1 screening for all semen donors.
• Establishing rigorous screening protocols is essential for preventing HIV-1 spread in assisted reproductive technologies.